Literature DB >> 16227356

Mortality from cirrhosis: lack of progress over the last 35 years.

C Gluud1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16227356      PMCID： PMC1774736          DOI： 10.1136/gut.2005.072876

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  43 in total

Review 1.  Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.

Authors:  Jean-Michel Pawlotsky; John G McHutchison
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

2.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

Review 3.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Chronic hepatitis B: update of recommendations.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

5.  Funding, disease area, and internal validity of hepatobiliary randomized clinical trials.

Authors:  Lise Lotte Kjaergard; Christian Gluud
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

Review 6.  Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients.

Authors:  G D'Amico; G Pietrosi; I Tarantino; L Pagliaro
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark.

Authors:  Henrik Toft Sørensen; Ane Marie Thulstrup; Lene Mellemkjar; Peter Jepsen; Erik Christensen; Jørgen H Olsen; Hendrik Vilstrup
Journal:  J Clin Epidemiol       Date:  2003-01       Impact factor: 6.437

Review 8.  Terlipressin for acute esophageal variceal hemorrhage.

Authors:  G Ioannou; J Doust; D C Rockey
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 9.  Anabolic-androgenic steroids for alcoholic liver disease.

Authors:  A Rambaldi; G Iaquinto; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  TIPS versus paracentesis for cirrhotic patients with refractory ascites.

Authors:  S Saab; J M Nieto; D Ly; B A Runyon
Journal:  Cochrane Database Syst Rev       Date:  2004
View more
  4 in total

1.  Are the opportunities to prevent alcohol related liver deaths in the UK in primary or secondary care? A retrospective clinical review and prospective interview study.

Authors:  Clare Verrill; Stewart Smith; Nick Sheron
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-06-15

2.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

Review 3.  Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010.

Authors:  Sadaf Ghajarieh Sepanlou; Fatemeh Malekzadeh; Farnaz Delavari; Mohsen Naghavi; Mohammad Hossein Forouzanfar; Maziar Moradi-Lakeh; Reza Malekzadeh; Hossein Poustchi; Akram Pourshams
Journal:  Middle East J Dig Dis       Date:  2015-10

Review 4.  Survival from alcoholic hepatitis has not improved over time.

Authors:  Emily Hughes; Laurence J Hopkins; Richard Parker
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.